Addressing the looming epidemic of metabolic dysfunction-associated steatotic liver disease in Pakistan: A call for action
Citation
Kamani, L., Rahat, A., & Yilmaz, Y. (2024). Addressing the looming epidemic of metabolic dysfunction-associated steatotic liver disease in Pakistan: A call for action. Hepatology forum, 5(1), 1–2. https://doi.org/10.14744/hf.2023.2023.0045Abstract
The term metabolic dysfunction-associated steatotic liver disease
(MASLD), which evolved from its predecessor, nonalcoholic fatty liver
disease (NAFLD),[1]